Completed PHASE4 INTERVENTIONAL 2-arm NCT03550287

Evaluation of the Effect of a Shiitake Extract on Lipid Profile in Subjects With Moderate Hyperlipidemia (Reducol)

A Clinical Trial to Evaluate the Effect of a Shiitake Mushroom Extract Supplement on Lipid Profile, Other Cardiovascular Risk Factors and the Microbiota in Subjects With and Moderate Hyperlipidemia

Sponsor: Instituto de Investigación Hospital Universitario La Paz

Conditions Cardiovascular Risk Factor Dietary Supplements Hypercholesterolemia Hyperlipidemias

Interventions Experimental product Placebo product

Updated 5 times since 2018 Last updated: Jan 12, 2022 Started: May 8, 2017 Primary completion: Jun 30, 2017 Completion: Dec 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Cardiovascular Risk Factor and Dietary Supplements and is currently completed. Instituto de Investigación Hospital Universitario La Paz leads this study, which shows 5 recorded versions since 2017 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Feb 2022 — Jul 2024 [monthly]

Completed PHASE4
Jan 2021 — Feb 2022 [monthly]

Completed PHASE4
Jul 2018 — Jan 2021 [monthly]

Completed PHASE4

First recorded

May 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Instituto de Investigación Hospital Universitario La Paz

Data source: Instituto de Investigación Hospital Universitario La Paz

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Madrid, Spain